Just in its latest quarter, ILMN registered a solid 23% bottom-line beat.
Shares of Intuitive Surgical (NASDAQ: ISRG) are down 33% this year, but none of the company's strengths are in any way diminished, and that means it's ripe for purchase on the dip. That means each sequencer sold implies a future trail of revenue that could last for years.
Recently, Zacks.com users have been paying close attention to Illumina (ILMN). This makes it worthwhile to examine what the stock has in store.